Results 1 to 10 of about 2,019 (111)
Journal of Current Ophthalmology, 2019 Purpose: To report a complication little reported until now: to and fro migration of the dexamethasone implant between the anterior and posterior segment (wandering Ozurdex) of sclera fixated intraocular lens (IOL) eyes and its effective management ...
Gaurav Kapoor, Vikas Ambiya
exaly +3 more sources
Management of ocular hypertension following intravitreal dexamethasone implant (ozurdex) [PDF]
American Journal of Ophthalmology Case ReportsPurpose: To evaluate the impact of intravitreal dexamethasone implantation (Ozurdex) on ocular hypertension (OHT) development and characterize its management with non-invasive or minimally-invasive modalities.
Jason Xiao, Mary Qiu
doaj +2 more sources
Ozurdex Completely Located Inside a Crystallized Lens - Results of 14 Months
American Journal of Ophthalmology Case Reports, 2016 Purpose: To report the therapeutic efficacy and results of an accidentally injected intralenticular sustained-release dexamethasone implant (Ozurdex) in a patient with macular edema secondary to central retinal vein occlusion at 14 months after injection.
Burhan Baskan +4 more
exaly +3 more sources
Case Reports in Ophthalmology, 2012 Purpose: To report a case of Coats’ disease managed with the dexamethasone intravitreal implant Ozurdex® (Allergan, Inc., Irvine, Calif., USA) combined with retinal photocoagulation.
Roberto Gallego-Pinazo +2 more
exaly +3 more sources
Ozurdex for the Treatment of a Patient With Birdshot Chorioretinopathy
Case Reports in Ophthalmology, 2015 We report a 57-year-old patient with birdshot chorioretinopathy (BCR) who was treated with bilateral Ozurdex injections. The patient's vitritis resolved, and visual acuity improved following this treatment.
Ala Moshiri, Elad Moisseiev
exaly +3 more sources
Acute Retinal Detachment Following Ozurdex Implant in a Nonvitrectomized Eye [PDF]
Case Reports in Ophthalmological MedicineIntravitreal injection (IVI) of antivascular endothelial growth factors and dexamethasone implants are among the most performed procedures in ophthalmology, as they are used to treat various retinal diseases. Although considered safe, some rare but sight-
Abdullah Alkhamees, Khaled Alsabah
doaj +2 more sources
Corneal Graft Failure Due to Migration of Ozurdex™ Implant Into the Anterior Chamber
American Journal of Ophthalmology Case Reports, 2017 Purpose: We report a case of corneal endothelial graft failure secondary to dexamethasone intravitreal implant (Ozurdex™) migration into the anterior chamber (AC).
Stephen Morgan, Saurabh Ghosh
exaly +3 more sources
Intravitreal dexamethasone implant (Ozurdex®) findings over time: ultrasound and ultra-widefield fundus photography [PDF]
International Journal of Retina and VitreousBackground Ozurdex® (Allergan®, AbbVie Company, North Chicago, Illinois, EUA), is composed of 0.7 mg of dexamethasone, fused in a solid biodegradable PLGA polymer, whose degradation occurs naturally in the vitreous cavity, usually in six months after its
Gabriela Assumpção Brito Pereira Pellegrini +2 more
doaj +2 more sources
From Monotherapy to Combination Strategies: Redefining Treatment Approaches for Multiple-Cause Macular Edema [PDF]
Clinical OphthalmologyQianwei Zhu,1 Xuchong Pan,1 Zhenni Du,1 Jianing Ying,2 Yiran Hu,1 Quanyong Yi,2 Xiangxiang Fu1 1Department of Ophthalmology, Yuyao Maternity and Child Health Care Hospital (Yuyao Second People’s Hospital), Ningbo, People’s Republic of China; 2Department ...
Zhu Q +6 more
doaj +2 more sources
Heliyon, 2022 Introduction: To report a case of accidental intralenticular Ozurdex injection in an eye with thicker lens. During the follow-up period of 15 months, the therapeutic effect of intralenticular Ozurdex was maintained.
Mu Li, Shiyun Jiang, Wen Chen
doaj +1 more source